MARTONE, Tiziana
 Distribuzione geografica
Continente #
NA - Nord America 946
EU - Europa 525
AS - Asia 249
AF - Africa 5
OC - Oceania 2
SA - Sud America 1
Totale 1.728
Nazione #
US - Stati Uniti d'America 930
CN - Cina 162
IT - Italia 97
IE - Irlanda 78
SE - Svezia 67
AT - Austria 51
UA - Ucraina 43
FR - Francia 42
FI - Finlandia 39
DE - Germania 38
KR - Corea 38
GB - Regno Unito 37
IN - India 20
CA - Canada 15
PL - Polonia 14
BE - Belgio 10
VN - Vietnam 8
JP - Giappone 7
UZ - Uzbekistan 6
SN - Senegal 4
SG - Singapore 3
CH - Svizzera 2
NL - Olanda 2
RU - Federazione Russa 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
DK - Danimarca 1
ES - Italia 1
ID - Indonesia 1
MU - Mauritius 1
MX - Messico 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
RO - Romania 1
TR - Turchia 1
Totale 1.728
Città #
Chandler 160
Beijing 114
Dublin 77
Ann Arbor 69
Ashburn 55
Vienna 51
Torino 50
Woodbridge 41
Jacksonville 38
Houston 37
Dearborn 36
Medford 31
Princeton 28
Nyköping 27
Villeurbanne 27
Fairfield 25
Wilmington 22
Warsaw 14
Fremont 13
Seattle 12
Toronto 11
Brussels 10
Cambridge 10
Boston 9
Milan 8
Nanjing 8
Boardman 7
Norwalk 7
Verona 7
Düsseldorf 6
Dong Ket 5
Hefei 5
Orio Canavese 5
Redwood City 5
Shanghai 5
Beinasco 4
New York 4
Pisa 4
Shenyang 4
Auburn Hills 3
Kumamoto 3
Kunming 3
Lachine 3
Wakefield 3
Alexandria 2
Bricherasio 2
Falls Church 2
Guangzhou 2
Los Angeles 2
Nanchang 2
Pune 2
San Mateo 2
Seoul 2
Washington 2
West Jordan 2
Wuhan 2
Zhengzhou 2
Amsterdam 1
Atlanta 1
Aurora 1
Basel 1
Brabrand 1
Böblingen 1
Chongqing 1
Chungnam 1
Dubai 1
Fairfax 1
Galveston 1
Gresham 1
Hebei 1
Hiroshima 1
Islamabad 1
Istanbul 1
Jiaxing 1
Kiel 1
Kuala Lumpur 1
Lappeenranta 1
Lima 1
Limerick 1
London 1
Munich 1
Nichelino 1
Noto 1
Ottawa 1
Padova 1
Pollein 1
Riverton 1
Saint Petersburg 1
San Diego 1
San Sebastián de los Reyes 1
Shenzhen 1
Stockholm 1
Taizhou 1
Tauranga 1
Tokyo 1
Turin 1
Xian 1
Zurich 1
Ürümqi 1
Totale 1.134
Nome #
Nestin expression and reactive phenomena in the mouse cochlea after kanamycin ototoxicity 215
Beyond 35 years of Parkinson’s disease: a comprehensive clinical and instrumental assessment 132
[Molecular markers study in pTNM of squamous carcinoma of the head and neck] 102
4-Aminobiphenyl-DNA adducts and p53 mutations in bladder cancer. 99
Association between hypermethylated tumor and paired surgical margins in head and neck squamous cell carcinomas 98
Prognostic relevance of CD105+ microvessel density inHNSCC patient outcome 93
Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential 91
Exposure to aromatic amines and ras and c-erbB-2 overexpression in bladder cancer. 89
White blood cell DNA adducts, smoking, and NAT2 and GSTM1 genotypes in bladder cancer: a case-control study. 87
Tobacco smoke, recurrences, and p53/bcl-2 expression in bladder cancer. 69
Constitutive expression of interleukin-18 in head and neck squamous carcinoma cells. Head Neck 69
Molecular metastases markers in head and neck squamous cell carcinoma: review of the literature 63
Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study 63
Prognostic impact of HER-2/neu expression on squamous head and neck carcinomas 58
Genetic background and outcome of Deep Brain Stimulation in Parkinson's disease 58
Perinatal asphyxia affects rat auditory processing: implications for auditory perceptual impairments in neurodevelopmental disorders 55
Extracellular Vesicles Released by Tumor Endothelial Cells Spread Immunosuppressive and Transforming Signals Through Various Recipient Cells 54
Towards gene therapy for deafness 50
Impact of polymorphisms in xeno(endo)biotic metabolism on pattern and frequency of p53 mutations in bladder cancer 47
Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas 47
Expanding the spectrum of movement disorders in Klinefelter syndrome 46
Staging of head and neck squamous cell carcinoma using the MET oncogene product as marker of tumor cells in lymph node metastases 37
Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas 35
G325R GBA mutation in Parkinson's disease: Disease course and long-term DBS outcome 33
15-Year Subthalamic Deep Brain Stimulation outcome in a Parkinson’s disease patient with Parkin gene mutation: a case report 5
Levodopa-carbidopa intestinal gel infusion (LCIG) in Parkinson disease with genetic mutations 1
Totale 1.796
Categoria #
all - tutte 5.303
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.303


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201941 0 0 0 0 0 0 0 0 0 0 25 16
2019/2020251 4 9 11 18 24 48 38 11 15 40 20 13
2020/2021218 11 71 14 6 12 4 15 13 29 14 11 18
2021/2022238 6 6 4 15 8 6 16 10 6 17 85 59
2022/2023437 41 33 14 35 47 105 25 31 69 11 17 9
2023/2024123 35 25 10 10 6 19 3 7 1 7 0 0
Totale 1.796